ArticleNeuro-oncology2025

Bayesian reappraisal of ACNS0332 and ACNS0334 strengthens subgroup treatment effects in high-risk pediatric Group 3 medulloblastoma.

Rahim Abo Kasem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.